Table 4. Substituted Heteroaryl Amide SAR.
![]() |
|||||
---|---|---|---|---|---|
| |||||
Cpd | A | R | mGlu5 pIC50a (± SEM) |
mGlu5 IC50 (nM) |
% Glu Maxa,b (± SEM) |
65 | N |
![]() |
<4.5 | >30,000 | — |
66 | N |
![]() |
<4.5 | >30,000 | — |
67 | N |
![]() |
6.72 ± 0.22 | 193 | 2.1 ± 0.8 |
68 | N |
![]() |
7.20 ± 0.06 | 62.4 | 1.6 ± 0.1 |
69 | N |
![]() |
7.00 ± 0.29 | 100 | 2.3 ± 0.6 |
70 | CF |
![]() |
6.00 ± 0.04 | 990 | 1.1 ± 0.75 |
71 | CF |
![]() |
<5.0c | >10,000 | 20 ± 10 |
72 | CF |
![]() |
5.33 ± 0.17 | 4640 | 19 ± 6 |
73 | CF |
![]() |
<4.5 | >30,000 | — |
74 | CF |
![]() |
<4.5 | >30,000 | — |
75 | CF |
![]() |
6.51 ± 0.15 | 311 | 1.7 ± 0.4 |
76 | CF |
![]() |
6.95 ± 0.29 | 111 | 2.0 ± 0.3 |
Calcium mobilization mGlu5 assay; values are average of n ≥ 3
Amplitude of response in the presence of 30 μM test compound as a percentage of maximal response (100 μM glutamate); average of n ≥ 3
CRC does not plateau